+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastrointestinal Drugs Market Research Reports

Abdominal Aneurysms - Pipeline Insight, 2025 - Product Thumbnail Image

Abdominal Aneurysms - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Chronic Cutaneous Ulcers - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Cutaneous Ulcers - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Chronic Norovirus Enteritis-Pipeline - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Norovirus Enteritis-Pipeline - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Congenital Diarrheal Disorders - Pipeline Insight, 2025 - Product Thumbnail Image

Congenital Diarrheal Disorders - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Postoperative Gastrointestinal Dysfunction - Pipeline Insight, 2025 - Product Thumbnail Image

Postoperative Gastrointestinal Dysfunction - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Gastro Intestinal Bleeding - Pipeline Insight, 2025 - Product Thumbnail Image

Gastro Intestinal Bleeding - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Intestinal Obstruction - Pipeline Insight, 2025 - Product Thumbnail Image

Intestinal Obstruction - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Lipodystrophy Syndrome (LS) - Pipeline Insight, 2025 - Product Thumbnail Image

Lipodystrophy Syndrome (LS) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Serotonin 3 Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Serotonin 3 Receptor Antagonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Biliary Atresia - Pipeline Insight, 2025 - Product Thumbnail Image

Biliary Atresia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Oral Mucositis - Pipeline Insight, 2025 - Product Thumbnail Image

Oral Mucositis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Pancreatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Pancreatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Gastroparesis - Pipeline Insight, 2025 - Product Thumbnail Image

Gastroparesis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Traveler's Diarrhea - Pipeline Insight, 2025 - Product Thumbnail Image

Traveler's Diarrhea - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Peptic Ulcer - Pipeline Insight, 2025 - Product Thumbnail Image

Peptic Ulcer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hypoglycemia- Pipeline Insight, 2025 - Product Thumbnail Image

Hypoglycemia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Ascites - Pipeline Insight, 2025 - Product Thumbnail Image

Ascites - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anal Fissure - Pipeline Insight, 2025 - Product Thumbnail Image

Anal Fissure - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Gastric Ulcers - Pipeline Insight, 2025 - Product Thumbnail Image

Gastric Ulcers - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Fecal Incontinence - Pipeline Insight, 2025 - Product Thumbnail Image

Fecal Incontinence - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists. The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more